Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis
JAMA Dermatologyn=211
💡
For adolescents and adults with moderate-to-severe atopic dermatitis, adding lebrikizumab to low- to mid-potency topical steroids for 16 weeks...
Clinical insight